Dapagliflozin Tablets

The Defense Logistics Agency (DLA) will issue a nationwide, unrestricted, fully‑competitive solicitation for a firm‑fixed‑price, requirements‑type contract to supply Dapagliflozin tablets (5 mg and 10 mg) in 30‑ and 90‑tablet bottles. The contract will have a one‑year base period with four one‑year option periods, establishing a national supply source for DoD, VA, Indian Health Service, and Bureau of Prisons customers. All qualified vendors may submit proposals; the solicitation will be posted on DIBBS and SAM.gov. Interested parties should contact the primary DLA representative for questions. • Product: Dapagliflozin 5 mg & 10 mg tablets, 30‑ and 90‑tablet bottles • Contract type: Firm‑fixed‑price, requirements contract (one‑year base + up to four 1‑yr options) • Scope: Nationwide supply to multiple federal health programs • Competition: Unrestricted, fully competitive (FAR Part 12 – commercial item) • Posting: DIBBS and SAM.gov (projected release October 2026) • Contact: Ryan Guarnere, (445) 737‑1729, [email protected]